Publications

To examine associations between 4 CD4 count measures as indicators of immune function and infection-related and infection-unrelated cancer risk in people living with HIV.

To identify novel correlates of subclinical CAA, markers of intestinal damage and cell trafficking/inflammation, in people living with HIV receiving antiretroviral therapy in the Canadian HIV/Aging Cohort study.

Considering the prevalence of M. genitalium infections among Montréal gbMSM.

To evaluate whether plasma soluble gp120 (sgp120) and a family of gp120-specific anti–cluster A antibodies, linked to CD4 depletion in vitro, contribute to chronic inflammation, immune dysfunction, and subclinical cardiovascular disease in participants of the Canadian HIV and Aging Cohort Study with undetectable viremia.

Evaluating whether plasmatic soluble gp120 (sgp120) and a family of gp120-specific anti-cluster A antibodies, linked to CD4 depletion in vitro, contribute to chronic inflammation, immune dysfunction, and sub-clinical cardiovascular disease in participants of the Canadian HIV and Aging cohort (CTN 272) with undetectable viremia.

Considering the association between sexual and/or gender minority identities and: (1) experiences of poor treatment by health professionals and (2) being unable to access health services among a cohort of women living with HIV in Metro Vancouver, Canada.

Comparing bone mineral density loss between women living with HIV and HIV-negative women and considering its association with low ovarian hormonal states.

Considering how the COVID-19 pandemic may disproportionately affect gay, bisexual, and other men who have sex with men (GBM), particularly related to HIV prevention and treatment outcomes.

Considering vaccine effectiveness in people living with HIV and/or who inject drugs

Considering preventative behaviour practices with respect to COVID-19 among people living with HIV